[Federal Register: February 19, 2004 (Volume 69, Number 33)]
[Notices]
[Page 7760]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19fe04-65]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on March 17, 2004, from 1
p.m. to 5 p.m.
Location: Food and Drug Administration, 8800 Rockville Pike, Bldg.
29B, Conference Room C, Bethesda, MD. This meeting will be held by a
telephone conference call. The public is welcome to attend the meeting
at the previously mentioned location. A speaker telephone will be
provided at the specified location for public participation in this
meeting.
Contact Person: William Freas or Denise H. Royster, Food and Drug
Administration, Center for Biologics Evaluations and Research (HFM-71),
1401 Rockville Pike, Rockville, MD, 20852, 301-827-0314, or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 3014512391. Please call the Information
Line for up-to-date information on this meeting.
Agenda: This committee will discuss recommendations pertaining to
the influenza virus vaccine formulation.
Procedure: On March 17, 2004, from 1 p.m. to 5 p.m., the meeting is
open to the public. Interested persons may present data, information,
or views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by March 11,
2004. Oral presentations from the public will be scheduled between
approximately 2 p.m. and 3 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before March 11, 2004, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public as its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact William Freas or
Denise H. Royster at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: February 11, 2004.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 04-3487 Filed 2-18-04; 8:45 am]
BILLING CODE 4160-01-S